Case Report: Effective management of adalimumab-induced acquired hemophilia A with the CyDRI protocol.

While the root cause of AHA is frequently idiopathic or associated with autoimmune diseases or malignancies, an increasing trend is observable with more cases attributable to certain medications, especially those with immunomodulatory properties [ 1 , 3 ].

also in 63,971 other papers